- Filed
- Mar 29, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2023 · Mar 29, 2024 | 4.38M sh |
| Capex | FY 2023 · Dec 31, 2023 | $0 |
| Capex | FY 2023 · Dec 31, 2022 | $900 |
| Shares Diluted | FY 2023 · Dec 31, 2022 | 4.38M sh |
| Operating Cash Flow | FY 2023 · Dec 31, 2022 | −$2.75M |
| Current Liabilities restated | FY 2023 · Dec 31, 2022 | $3.39M |
| Total Liabilities restated | FY 2023 · Dec 31, 2022 | $3.39M |
| Current Assets restated | FY 2023 · Dec 31, 2022 | $2.46M |
| Total Assets restated | FY 2023 · Dec 31, 2022 | $2.46M |
| Eps Diluted | FY 2023 · Dec 31, 2022 | −$0.23 |
| Eps Basic | FY 2023 · Dec 31, 2022 | −$0.23 |
| Sga Expense | FY 2023 · Dec 31, 2022 | $509.19K |
| Net Income | FY 2023 · Dec 31, 2022 | −$1.01M |
| Operating Income | FY 2023 · Dec 31, 2022 | −$1.01M |
| Gross Profit | FY 2023 · Dec 31, 2022 | $73.06K |
| Cost Of Revenue | FY 2023 · Dec 31, 2022 | $517.24K |
| Stockholders Equity restated | FY 2023 · Dec 31, 2021 | −$92.29K |